Changing trends in the epidemiology of Candida blood stream infections: A matter for concern?*
- 1 March 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 38 (3), 990-992
- https://doi.org/10.1097/ccm.0b013e3181d16866
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream InfectionsJAMA Internal Medicine, 2009
- The changing epidemiology of invasive candidiasisCancer, 2008
- Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care UnitClinical Infectious Diseases, 2008
- Epidemiology, Risk Factors, and Outcomes of Candida albicans Versus Non-albicans Candidemia in Nonneutropenic PatientsAnnals of Pharmacotherapy, 2007
- Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemiaCritical Care Medicine, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Sepsis in European intensive care units: Results of the SOAP study*Critical Care Medicine, 2006
- Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control StudyAntimicrobial Agents and Chemotherapy, 2005
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004